CIMIT is committed to collaboration with industry, appreciating its essential
role in bringing innovation to the patient. Through our offices of Business
and Technology Development, we encourage and facilitate these important partnerships.
We thank the following members of our Industry Liaison Program for their involvement
and support of our efforts: For more information, go to the Industry Liaison
Program page or the Join CIMIT form.
| |
|
 |
John
E. Abele
Mr.
Abele is the Founder Chairman of Boston Scientific Corporation in Natick,
MA, a pioneer and leader in the field of "Less Invasive Medicine",
offering a broad range of products for cardiology, gastroenterology, radiology,
urology and surgery.
Prior to starting BSC in 1979, he was President of Medi-tech (a predecessor
to BSC) for ten years. Before that he held various development, sales
and general management positions for several companies.
In 1965 he was one of the founders of the Association for the Advancement
of Medical Instrumentation (AAMI) and remained a director for twelve years.
He has been associated, directly or indirectly, with many technical developments
including implantable pacemakers, artificial kidneys, blood gas measurement
instruments, osmometers, balloon dilatation catheters and numerous "interventional
devices".
Mr. Abele graduated from Amherst College with a degree in Physics and
Philosophy. He has numerous patents and has published and lectured extensively
on the technology of various medical devices and on technical, social,
economic and political trends affecting healthcare. His major interests
are science, education and the process by which new technology is invented,
developed and introduced to society.
|
| |
|
 |
Paul
Citron
Paul
Citron is the Vice President of Science and Technology at Medtronic, Inc.,
in Minneapolis, MN. He has responsibility for corporate-wide assessment
and coordination of technology and for establishing and prioritization
of corporate research. Prior to this, he held several research and technology
positions within Medtronic.
Mr. Citron was awarded a B.S. in electrical engineering from Drexel University
in Philadelphia and a M.S. in electrical engineering from the University
of Minnesota.
He was elected Founding Fellow of the American Institute of Medical and
Biological Engineering (AIMBE), has twice won the American College of
Cardiology Governor’s Award for Excellence and was inducted as a
Fellow of the Medtronic Bakken Society. He has authored many publications
and holds several medical device pacing-related patents. In 1980 he was
given Medtronic’s "Invention of Distinction" award for
his role as co-inventor of the tined pacing lead. |
| |
|
 |
Cynthia
P. Danaher
Cynthia
Danaher, who formerly led Hewlett-Packard Company in the Medical Products
Group, is currently consulting in the field.
Ms. Danaher assumed her position at Hewlett-Packard in December, 1995.
Prior to that, she was General Manager of MPG’s Imaging Systems Division,
the business responsible for the management, design, manufacture, marketing
and support of imaging system products for the healthcare marketplace
worldwide. She had joined the Imaging Systems Division in 1990 as its
Marketing Manager. Ms. Danaher came to Hewlett-Packard in 1984 to work
in sales development for ultrasound imaging.
As Health Policy Specialist from 1989 to 1990, she was responsible for
representing Hewlett-Packard’s interests in Massachusetts Health
Care Policy, including Chapter 23, the uncompensated care pool, and reimbursement
and legislative issues. On the federal level, she worked with Healthcare
Information Manufacturers Association (HIMA) and the Institute of Medicine
on technology transfer. She also led an internal educational program on
outcomes measurements and the Resource-Based, Relative Value Scale.
Ms. Danaher has a bachelor’s degree in biology from the University
of Vermont in Burlington, and a master’s degree in business administration
from Harvard University.
|
| |
|
 |
Alexander
V. d’Arbeloff
Mr.
d’Arbeloff is Chairman of Teradyne, Inc., in Boston, MA, a leading
manufacturer of automatic test equipment and interconnection systems for
the electronics and telecommunications industries. He cofounded Teradyne
in 1960 and served as Vice President until 1971, when he became President
and Chief Executive Officer, adding the title of Chairman in 1977.
Mr. d’Arbeloff is also Chairman of the MIT Corporation. He has served
on MIT’s Corporation Development Committee and on visiting committees
for the Departments of Economics, Electrical Engineering and Computer
Science, and Mechanical Engineering. In addition, Mr. d’Arbeloff
has taught classes at the Sloan School of Management, and developed and
teaches a course on management and entrepreneurship for graduate students
in mechanical engineering.
Mr. d’Arbeloff serves on the boards of a number of high-tech corporations.
He is a Director and past Chairman of the Massachusetts High Technology
Council and a trustee of Massachusetts General Hospital and the New England
Conservatory. He earned the SB in management from MIT.
|
| |
|
 |
Ronald
Dollens
Ronald
Dollens is President and Chief Executive Officer of Guidant Corporation,
a $2.4 billion company traded on the New York and Pacific Stock Exchanges
(NYSE and PCX: GDT). Prior to the formation of Guidant in 1994, Mr. Dollens
served as President of Eli Lilly and Companyâs Medical Devices and Diagnostics
Division (MDD). In 1985, Mr. Dollens was named Senior Vice President,
Sales, Marketing, and Product Development for Advanced Cardiovascular
Systems (ACS), an MDD company headquartered in Santa Clara, California.
In 1988, he became President and Chief Executive Officer of ACS.
Mr. Dollens received a Bachelor of Science degree in pharmacy from Purdue
University, and a Master of Business Administration degree in marketing
from Indiana University. Mr. Dollens also served as Chairman of the Board
of the Health Industry Manufacturers Association (HIMA) until recently.
He serves on the Boards of the Health Industry Manufacturers Association,
the Beckman Coulter Corporation, and the Indiana Health Industry Forum.
|
| |
|
 |
Scott
C. Donnelly
Mr.
Donnelly is currently Senior Vice President of General Electric Corporate
R&D. Formerly, he was the Vice President, Medical Systems Global Technology
Operation at GE in Milwaukee, WI.
Mr. Donnelly assumed his current position in October of 1997. Prior to
that he was General Manager, Industrial Systems Technology, which followed
his appointment as Manager of Technology and Systems Development for GE
Motors and Industrial Systems
Mr. Donnelly first joined GE Aerospace in Syracuse, New York in 1989 and
led large engineering organizations in the Ocean, Radar and Sensor Systems
business. During the disposition of GE Aerospace to Martin Marietta, Scott
served as the Manager of Engineering for the Australian subsidiary located
in Canberra, Australia.
Mr. Donnelly received his bachelor’s degree in Electrical Engineering
and Computer Science from the University of Colorado. After graduation,
he joined General Dynamics as a design engineer working in the area of
advanced computer architecture development and later formed a semiconductor
design company as part of a joint venture between Intel and Westinghouse.
|
| |
|
 |
John
Larkin Thompson
John Larkin Thompson is Of Counsel at Nutter, McClennen and Fish in Boston,
MA. In 1992, Mr. Larkin Thompson retired as President and Chief Executive
Officer of Blue Cross and Blue Shield of Massachusetts, Inc. Prior to
this, Mr. Larkin Thompson practiced law with the firm of Palmer and Dodge.
Mr. Larkin Thompson received his undergraduate degree from Villanova University,
an M.S. from Columbia University Graduate School of Business and his law
degree from Boston University School of Law, Cum Laude.
|
| |
|
 |
George
J. Rabstejnek
Mr.
Rabstejnek is the Chairman of Bluelight, Inc. a company dedicated to the
commercial exploitation of Gallium Nitride film technology developed by
the Photonics Center at Boston University. He is also in the process of
developing several other organizations designed to accelerate the commercialization
of technology from research universities. Mr. Rabstejnek serves as Vice
Chairman of the Massachusetts Eye and Ear Infirmary (a Harvard teaching
hospital) where he chairs the research committee and founded a neural
prosthesis research laboratory (a joint venture between the Harvard Teaching
Hospitals, Draper Laboratories and Massachusetts Institute of Technology).
He actively consults with several graduate business schools of major universities
in the United States.
Mr. Rabstejnek retired in 1993 as Chairman and CEO of Harbridge House,
a global consulting firm founded in 1950 at the Harvard Business School.
As an analyst and consultant, Mr. Rabstejnek provided a broad range of
services to industry and government focusing primarily on strategic issues
in large, complex organizations in industry and government.
Prior to joining Harbridge House, Mr. Rabstejnek was a project manager
for the Systems Management Division of IBM. He managed functions in research,
engineering and systems design.
Mr. Rabstejnek holds a BS degree in Industrial Engineering from Georgia
Institute of Technology and is a graduate of the Harvard University Graduate
School of Business Administration, Advanced Management Program.
|
| |
|
 |
Frank
E. Samuel, Jr.
Mr.
Samuel is currently the Science Advisor to the Governor of Ohio. Formerly,
he was President of the Edison BioTechnology Center, Inc. in Cleveland,
OH. He received his law degree from Harvard Law School and his B.A. from
Hiram College. He was a Fulbright Scholar at the University of Leiden
in The Netherlands.
From 1984 to 1989, Mr. Samuel was President of the Health Industry Manufacturers
Association (HIMA). HIMA is the nation’s leading organization representing
health devices, diagnostics and information systems manufacturers on federal,
state and international government issues. Prior to that position, he
practiced law in Washington, D.C. where he specialized in regulatory,
legislative and other governmental programs affecting healthcare technology
and services. Earlier in his career, he was Vice President and General
Counsel for HIMA and served in a variety of positions in the US. Department
of Health, Education and Welfare including Deputy Assistant Secretary
for Legislation (Health). |
| |
|
 |
Thomas
Sommer
Mr. Sommer is the Executive Director of the Massachusetts Medical Device
Industry Council (MassMEDIC) in Westborough, MA. In his current role,
Mr. Sommer works to strengthen MassMEDIC’s ties to the Commonwealth’s
Congressional delegation and the FDA’s New England district office;
promote sensible reform of the US Food and Drug Administration; and establish
a working relationship with the Governor’s office and state legislature.
Previously, Mr. Sommer served as Director of the Tech Forum at the Massachusetts
Technology Collaborative (MTC) and as Vice President of the New England
Council, a regional business organization, where he was primarily responsible
for coordinating the energy and environmental affairs policy agenda. He
received his B.A. in Political Science from Boston College and a M.P.A.
from Harvard University. |
| |
|
 |
Joshua
Tolkoff
Josh Tolkoff is President of Seedling Enterprises, LLC, a company focusing
on medical device technology development and consulting. Before his current
position, he was President and Founder of ACT Medical, Inc. of Newton,
MA. As CEO of this medical device manufacturing firm, Mr. Tolkoff focused
on customer relations, research and development, project performance and
regulatory conformance. Prior to founding ACT, Mr. Tolkoff created Harbor
Medical Devices, Inc., a venture financed company that developed, manufactured
and marketed drug delivery infusion medical devices. Prior to founding
these two entities, he held engineering positions at Massachusetts General
Hospital and the Medi-tech division of Boston Scientific, Inc. Mr. Tolkoff
currently holds nearly 20 patents and 10 publications. He is a graduate
of Harvard College with a degree in Engineering and Applied Physics. He
received a M.S. from MIT. |
| |
|
